{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:47:40Z","timestamp":1786996060435,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1378\/chest.117.2_suppl.29s","type":"journal-article","created":{"date-parts":[[2003,6,13]],"date-time":"2003-06-13T20:09:19Z","timestamp":1055534959000},"page":"29S-32S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"S","title":["The Reality of Drug Use in COPD"],"prefix":"10.1016","volume":"117","author":[{"given":"Michael","family":"Rudolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.117.2_suppl.29S_bib1","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.95.08081398","article-title":"Optimal assessment and management of chronic obstructive pulmonary disease (COPD): The European Respiratory Society Task Force","volume":"8","author":"Siafakas","year":"1995","journal-title":"Eur Respir J"},{"issue":"suppl 5","key":"10.1378\/chest.117.2_suppl.29S_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/thx.52.2008.S1.5","article-title":"BTS guidelines for the management of chronic obstructive pulmonary disease: the COPD Guidelines Group of the Standards of Care Committee of the BTS","volume":"52","year":"1997","journal-title":"Thorax"},{"issue":"suppl 25","key":"10.1378\/chest.117.2_suppl.29S_bib3","first-page":"427S","article-title":"Therapeutic equivalence of ipratropium bromide MDIs formulated with HFA or CFC propellant in long-term treatment of COPD [abstract]","volume":"10","author":"Wedzicha","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.117.2_suppl.29S_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1183\/09031936.97.10040815","article-title":"An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease","volume":"10","author":"Boyd","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.117.2_suppl.29S_bib5","first-page":"A21","article-title":"Inhaled steroids in obstructive lung disease in Europe, the ISOLDE trial: protocol and progress [abstract]","volume":"149","author":"Burge","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.117.2_suppl.29S_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(97)03471-5","article-title":"Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease: International COPD Study Group","volume":"351","author":"Paggiaro","year":"1998","journal-title":"Lancet"},{"key":"10.1378\/chest.117.2_suppl.29S_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/thx.54.1.7","article-title":"Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis","volume":"54","author":"van Grunsven","year":"1999","journal-title":"Thorax"},{"key":"10.1378\/chest.117.2_suppl.29S_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0954-6111(99)90001-X","article-title":"An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease","volume":"93","author":"Jarad","year":"1999","journal-title":"Respir Med"},{"key":"10.1378\/chest.117.2_suppl.29S_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1183\/09031936.93.04030257","article-title":"Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey","volume":"4","author":"Lundback","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.117.2_suppl.29S_bib10","first-page":"95","article-title":"Prevalence rates of respiratory symptoms in Italian general population samples exposed to different levels of air pollution","volume":"94","author":"Viege","year":"1991","journal-title":"Environ Health Perspect"},{"issue":"suppl","key":"10.1378\/chest.117.2_suppl.29S_bib11","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1164\/ajrccm\/140.3_Pt_2.S19","article-title":"Morbidity and mortality from chronic obstructive pulmonary disease","volume":"140","author":"Manfreda","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.117.2_suppl.29S_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/thx.51.2.164","article-title":"Prevalence and treatment of chronic airways obstruction in adults over the age of 45","volume":"51","author":"Renwick","year":"1996","journal-title":"Thorax"},{"key":"10.1378\/chest.117.2_suppl.29S_bib13","first-page":"29","article-title":"General practitioner prescribing habits in asthma\/COPD","volume":"5","author":"Peperell","year":"1997","journal-title":"Asthma Gen Pract"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215527530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215527530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:24:57Z","timestamp":1757921097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215527530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["S0012369215527530"],"URL":"https:\/\/doi.org\/10.1378\/chest.117.2_suppl.29s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Reality of Drug Use in COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.117.2_suppl.29S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}